The genetic testing company 23andMe announced it was laying off more than 200 employees, or roughly 40% of its entire ...

Orange County’s third largest medical diagnostics and testing company is being acquired by a fast-growing Chicago-based firm ...

Explore how the genetic testing industry is transforming healthcare through precision medicine ensuring patient privacy and ...

CEO Eric Lefkofsky said the purchase of Ambry Genetics will expand Tempus’ testing portfolio and bring in a fast-growing ...

DNA commodification is no longer a future concern; it’s a present reality. Beyond charging users for their services, some ...

Tempus AI agreed to buy genetic testing company Ambry Genetics for $375 million in cash and $225 million in shares. Chicago-based Tempus, which makes AI-enabled precision medicine solutions ...

The company is scheduled to hold its third quarter 2024 earnings conference call after the market closes on Thursday November 7, 2024, and intends to provide additional information regarding its ...

In the video, Heliospect Genomics sells its services to customers ... service raises moral and medical questions. Duggan Wells, professor of reproductive genetics at the University of Oxford ...